|
|
 |
|
 |
|
|
| |
| |
Drug Classification Change Notice - New Prohibited Practice Designation
| Please be advised that the RCI Board of Directors on April 14, 2002 approved the
recommendation(s) of its Drug Testing Standards and Practices (DTSP) Committee to establish a
new category known as “Prohibited Practices.” |
A) The possession and/or use of a drug, substance or medication, specified below, on the
premises of a facility under the jurisdiction of the regulatory body for which a recognized analytical
method has not been developed to detect and confirm the administration of such substance;
or the use of which may endanger the health and welfare of the horse or endanger the safety
of the rider or driver; or the use of which may adversely affect the integrity of racing:
- Erythropoietin
- Darbepoietin
The possession and/or use of a drug, substance, or medication on the premises of a facility
under the jurisdiction of the regulatory body that has not been approved by the United States
Food and Drug Administration (FDA) for use in the United States. |
|
|
|
|
|